EcoDrugPlus

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSOMYG00000017693
Gene Symbol: GRIN2BB
1 Cross references
251 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSOMYG00000040212
Gene Symbol: GRM2B
1 Cross references
200 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSOMYG00000039835
Gene Symbol: GRM2B
1 Cross references
200 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSOMYG00000020476
Gene Symbol: GRM3
1 Cross references
208 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSOMYG00000004532
Gene Symbol: GRM3
1 Cross references
208 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSOMYG00000020604
Gene Symbol: GLSA
1 Cross references
221 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSOMYG00000037999
Gene Symbol: GLSA
1 Cross references
221 Possible Orthologues:

Glutaminase B

Ensembl ID : ENSOMYG00000032746
Gene Symbol: GLSB
1 Cross references
223 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSOMYG00000000426
Gene Symbol: GSK3A
1 Cross references
182 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSOMYG00000046825
Gene Symbol: GSK3AA
1 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSOMYG00000026153
Gene Symbol: GSK3AA
1 Cross references
182 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSOMYG00000000310
Gene Symbol: GSK3AB
1 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).